GERN » Topics » Fair Value of Derivatives

These excerpts taken from the GERN 10-K filed Feb 27, 2009.

Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and marked to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as an unrealized gain (loss) on fair value of derivatives. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

     Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. Use of this model requires us to make assumptions regarding stock volatility, dividend yields, expected term of the warrants and non-employee options and risk-free interest rates. Expected volatilities are based on historical volatilities of our stock. The expected term of warrants and non-employee options represent the contractual term of the instruments. The risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields for the remaining term of the instrument. If factors change and we employ different assumptions in future periods, the fair value of these warrants and non-employee options reflected as of each balance sheet date and the resulting change in fair value that we record may differ significantly from what we have recorded in previous periods. As of December 31, 2008, we have not revised the method in which we derive assumptions in order to estimate fair values of warrants and non-employee options, classified as assets or liabilities, and we do not expect revisions in the future.

Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and marked to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as an unrealized gain (loss) on fair value of derivatives. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

     Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. Use of this model requires us to make assumptions regarding stock volatility, dividend yields, expected term of the warrants and non-employee options and risk-free interest rates. Expected volatilities are based on historical volatilities of our stock. The expected term of warrants and non-employee options represent the contractual term of the instruments. The risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields for the remaining term of the instrument. If factors change and we employ different assumptions in future periods, the fair value of these warrants and non-employee options reflected as of each balance sheet date and the resulting change in fair value that we record may differ significantly from what we have recorded in previous periods. As of December 31, 2008, we have not revised the method in which we derive assumptions in order to estimate fair values of warrants and non-employee options, classified as assets or liabilities, and we do not expect revisions in the future.

Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and marked to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as an unrealized gain (loss) on fair value of derivatives. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

     Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. Use of this model requires us to make assumptions regarding stock volatility, dividend yields, expected term of the warrants and non-employee options and risk-free interest rates. Expected volatilities are based on historical volatilities of our stock. The expected term of warrants and non-employee options represent the contractual term of the instruments. The risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields for the remaining term of the instrument. If factors change and we employ different assumptions in future periods, the fair value of these warrants and non-employee options reflected as of each balance sheet date and the resulting change in fair value that we record may differ significantly from what we have recorded in previous periods. As of December 31, 2008, we have not revised the method in which we derive assumptions in order to estimate fair values of warrants and non-employee options, classified as assets or liabilities, and we do not expect revisions in the future.

Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and marked to fair value at each financial
reporting date. The change in fair value of the warrants and non-employee
options is recorded in the consolidated statements of operations as an
unrealized gain (loss) on fair value of derivatives. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


     Fair value
of warrants and non-employee options is estimated using the Black Scholes
option-pricing model. Use of this model requires us to make assumptions
regarding stock volatility, dividend yields, expected term of the warrants and
non-employee options and risk-free interest rates. Expected volatilities are
based on historical volatilities of our stock. The expected term of warrants and
non-employee options represent the contractual term of the instruments. The
risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields
for the remaining term of the instrument. If factors change and we employ
different assumptions in future periods, the fair value of these warrants and
non-employee options reflected as of each balance sheet date and the resulting
change in fair value that we record may differ significantly from what we have
recorded in previous periods. As of December 31, 2008, we have not revised the
method in which we derive assumptions in order to estimate fair values of
warrants and non-employee options, classified as assets or liabilities, and we
do not expect revisions in the future.


Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and marked to fair value at each financial
reporting date. The change in fair value of the warrants and non-employee
options is recorded in the consolidated statements of operations as an
unrealized gain (loss) on fair value of derivatives. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


     Fair value
of warrants and non-employee options is estimated using the Black Scholes
option-pricing model. Use of this model requires us to make assumptions
regarding stock volatility, dividend yields, expected term of the warrants and
non-employee options and risk-free interest rates. Expected volatilities are
based on historical volatilities of our stock. The expected term of warrants and
non-employee options represent the contractual term of the instruments. The
risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields
for the remaining term of the instrument. If factors change and we employ
different assumptions in future periods, the fair value of these warrants and
non-employee options reflected as of each balance sheet date and the resulting
change in fair value that we record may differ significantly from what we have
recorded in previous periods. As of December 31, 2008, we have not revised the
method in which we derive assumptions in order to estimate fair values of
warrants and non-employee options, classified as assets or liabilities, and we
do not expect revisions in the future.


Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and marked to fair value at each financial
reporting date. The change in fair value of the warrants and non-employee
options is recorded in the consolidated statements of operations as an
unrealized gain (loss) on fair value of derivatives. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


     Fair value
of warrants and non-employee options is estimated using the Black Scholes
option-pricing model. Use of this model requires us to make assumptions
regarding stock volatility, dividend yields, expected term of the warrants and
non-employee options and risk-free interest rates. Expected volatilities are
based on historical volatilities of our stock. The expected term of warrants and
non-employee options represent the contractual term of the instruments. The
risk-free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields
for the remaining term of the instrument. If factors change and we employ
different assumptions in future periods, the fair value of these warrants and
non-employee options reflected as of each balance sheet date and the resulting
change in fair value that we record may differ significantly from what we have
recorded in previous periods. As of December 31, 2008, we have not revised the
method in which we derive assumptions in order to estimate fair values of
warrants and non-employee options, classified as assets or liabilities, and we
do not expect revisions in the future.


Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and adjusted to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as unrealized gain (loss) on fair value of derivatives. Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and adjusted to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as unrealized gain (loss) on fair value of derivatives. Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

Fair Value of Derivatives

     We apply the provisions of several accounting pronouncements, including Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine whether financial instruments or a component of a financial instrument should be classified within assets, liabilities or stockholders’ equity.

     For warrants and non-employee options classified as assets or liabilities, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and adjusted to fair value at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as unrealized gain (loss) on fair value of derivatives. Fair value of warrants and non-employee options is estimated using the Black Scholes option-pricing model. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are otherwise modified to remove the provisions which require this treatment, at which time these instruments are marked to fair value and reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and adjusted to fair value at each financial reporting date.
The change in fair value of the warrants and non-employee options is recorded in
the consolidated statements of operations as unrealized gain (loss) on fair
value of derivatives. Fair value of warrants and non-employee options is
estimated using the Black Scholes option-pricing model. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and adjusted to fair value at each financial reporting date.
The change in fair value of the warrants and non-employee options is recorded in
the consolidated statements of operations as unrealized gain (loss) on fair
value of derivatives. Fair value of warrants and non-employee options is
estimated using the Black Scholes option-pricing model. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


Fair Value of
Derivatives


     We apply the
provisions of several accounting pronouncements, including Statement of
Financial Accounting Standards No. 133, “Accounting for Derivative Instruments
and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards
No. 150, “Accounting for Certain Financial Instruments with Characteristics of
Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue
00-19, “Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) to determine
whether financial instruments or a component of a financial instrument should be
classified within assets, liabilities or stockholders’ equity.


     For warrants
and non-employee options classified as assets or liabilities, the fair value of
these instruments is recorded on the consolidated balance sheet at inception of
such classification and adjusted to fair value at each financial reporting date.
The change in fair value of the warrants and non-employee options is recorded in
the consolidated statements of operations as unrealized gain (loss) on fair
value of derivatives. Fair value of warrants and non-employee options is
estimated using the Black Scholes option-pricing model. The warrants and
non-employee options continue to be reported as an asset or liability until such
time as the instruments are exercised or expire or are otherwise modified to
remove the provisions which require this treatment, at which time these
instruments are marked to fair value and reclassified from assets or liabilities
to stockholders’ equity. For warrants and non-employee options classified as
permanent equity, the fair value of the warrants and non-employee options is
recorded in stockholders’ equity and no further adjustments are made.


These excerpts taken from the GERN 10-K filed Feb 28, 2008.

Fair Value of Derivatives

     We apply the provisions of Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” (Issue 00-19) in accounting for derivative financial instruments.

     For warrants and non-employee options classified as assets or liabilities under Issue 00-19, the fair value of these instruments is recorded on the consolidated balance sheet at inception of such classification and marked to market at each financial reporting date. The change in fair value of the warrants and non-employee options is recorded in the consolidated statements of operations as an unrealized gain (loss) on fair value of derivatives. Fair value of warrants and non-employee options subject to Issue 00-19 is estimated using the Black Scholes option-pricing model. The warrants and non-employee options continue to be reported as an asset or liability until such time as the instruments are exercised or expire or are

52


GERON CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

otherwise modified to remove the provisions which require this treatment, at which time the fair value of these instruments is reclassified from assets or liabilities to stockholders’ equity. For warrants and non-employee options classified as permanent equity under Issue 00-19, the fair value of the warrants and non-employee options is recorded in stockholders’ equity and no further adjustments are made.

Fair Value of
Derivatives


     We apply the
provisions of Statement of Financial Accounting Standards No. 133, “Accounting
for Derivative Instruments and Hedging Activities,” (SFAS 133), Statement of
Financial Accounting Standards No. 150, “Accounting for Certain Financial
Instruments with Characteristics of Both Liabilities and Equity,” (SFAS 150) and
Emerging Issues Task Force Issue 00-19, “Accounting for Derivative Financial
Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,”
(Issue 00-19) in accounting for derivative financial instruments.


     For warrants
and non-employee options classified as assets or liabilities under Issue 00-19,
the fair value of these instruments is recorded on the consolidated balance
sheet at inception of such classification and marked to market at each financial
reporting date. The change in fair value of the warrants and non-employee
options is recorded in the consolidated statements of operations as an
unrealized gain (loss) on fair value of derivatives. Fair value of warrants and
non-employee options subject to Issue 00-19 is estimated using the Black Scholes
option-pricing model. The warrants and non-employee options continue to be
reported as an asset or liability until such time as the instruments are
exercised or expire or are


52





GERON
CORPORATION
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS


otherwise modified to remove the
provisions which require this treatment, at which time the fair value of these
instruments is reclassified from assets or liabilities to stockholders’ equity.
For warrants and non-employee options classified as permanent equity under Issue
00-19, the fair value of the warrants and non-employee options is recorded in
stockholders’ equity and no further adjustments are made.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki